BioSpace News Archive

Enterome announces the creation of its international Scientific Advisory Board and Medical Advisory Group comprising highly respected and influential scientific and clinical leaders in oncology and immunotherapy.

BrainStorm Cell Therapeutics Inc. announced that it will hold a conference call to update shareholders on financial results for the First Quarter ended March 31, 2023, and provide a corporate update, at 8:00 a.m. Eastern Time on Monday, May 15th.

Novavax, Inc. announced that its COVID-Influenza Combination, stand-alone influenza and high-dose COVID vaccine candidates all showed a reassuring preliminary safety profile as well as comparable reactogenicity to individual Novavax influenza and COVID vaccine candidates or authorized influenza vaccine comparators.

Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, reported financial results for the first quarter ended April 1, 2023.

Perrigo Company plc (NYSE: PRGO) (“Perrigo” or the “Company”), a leading provider of Consumer Self-Care Products, today announced financial results from continuing operations for the first quarter ended April 1, 2023.

Salipro Biotech AB and DyNAbind GmbH, two leading biotech companies, announced the achievement of a key milestone from their collaboration aimed to revolutionize drug discovery against difficult-to-drug targets.

Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, announced it will participate in a fireside chat at the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day in New York City on Monday, May 15, 2023.

BioCardia®, Inc. announces that the United States Patent Office has granted Patent Number 11,642,377.

Evoke Pharma, Inc., and EVERSANA™ announced the details of its presentation at Digestive Disease Week 2023 demonstrating that GIMOTI reduces healthcare resource utilization for patients with diabetic gastroparesis versus patients on oral metoclopramide.

Trevena, Inc. announced that it will release its financial results for the first quarter ended March 31, 2023, prior to the market open on Monday, May 15, 2023.